Applications are now open for designated RN prescribers to get a PBS prescriber number. The Chief Nurse has shared the latest milestones and a new one-stop website for nurses and employers.
A new umbrella review brings together more than a decade of evidence on specialist cancer nurse-led care. It finds nurses make their strongest impact in self-management support, symptom management and patient satisfaction, with clear messages for workforce planning.
From 1 October 2026, Triptorelin 3.75mg (Diphereline®) will become available on the PBS for the treatment of a range of women’s health conditions, including breast cancer, endometriosis and uterine fibrosis.
Australia’s first National Gynaecological Cancer Roundtable has brought together more than 40 leaders from government, research, healthcare and the lived-experience community to identify shared priorities for improving outcomes for people affected by gynaecological cancers.
